Submitted URL: http://lb.ophthalmologybreakingnews.com/eu/c/tq/102D93AB89B74DBEA488D01CF4796ED9/a56177cfe6bcc368065d2c53b59358c4/?i=b19f9c9f418ddf1bbd1...
Effective URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=ema...
Submission: On March 01 via manual from AE — Scanned from DE

Summary

This website contacted 11 IPs in 4 countries across 9 domains to perform 45 HTTP transactions. The main IP is 188.132.199.152, located in Turkey and belongs to TR-PENTECH-AS, TR. The main domain is ophthalmologybreakingnews.com.
TLS certificate: Issued by R3 on January 31st 2024. Valid for: 3 months.
This is the only time ophthalmologybreakingnews.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

Apex Domain
Subdomains
Transfer
26 ophthalmologybreakingnews.com
lb.ophthalmologybreakingnews.com
ophthalmologybreakingnews.com
1 MB
5 google.com
fundingchoicesmessages.google.com — Cisco Umbrella Rank: 647
region1.analytics.google.com — Cisco Umbrella Rank: 2656
179 KB
4 gstatic.com
fonts.gstatic.com
204 KB
3 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 40
247 KB
2 doubleclick.net
googleads.g.doubleclick.net — Cisco Umbrella Rank: 35
stats.g.doubleclick.net — Cisco Umbrella Rank: 84
5 KB
2 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 30
8 KB
2 googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 104
188 KB
1 googleusercontent.com
lh3.googleusercontent.com — Cisco Umbrella Rank: 46
2 KB
1 google.de
www.google.de — Cisco Umbrella Rank: 6744
408 B
45 9
Domain Requested by
25 ophthalmologybreakingnews.com ophthalmologybreakingnews.com
4 fonts.gstatic.com fonts.googleapis.com
ophthalmologybreakingnews.com
4 fundingchoicesmessages.google.com ophthalmologybreakingnews.com
pagead2.googlesyndication.com
3 www.googletagmanager.com ophthalmologybreakingnews.com
www.googletagmanager.com
2 fonts.googleapis.com ophthalmologybreakingnews.com
2 pagead2.googlesyndication.com ophthalmologybreakingnews.com
pagead2.googlesyndication.com
1 lh3.googleusercontent.com ophthalmologybreakingnews.com
1 www.google.de ophthalmologybreakingnews.com
1 stats.g.doubleclick.net www.googletagmanager.com
1 region1.analytics.google.com www.googletagmanager.com
1 googleads.g.doubleclick.net pagead2.googlesyndication.com
1 lb.ophthalmologybreakingnews.com 1 redirects
45 12
Subject Issuer Validity Valid
ophthalmologybreakingnews.com
R3
2024-01-31 -
2024-04-30
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
*.google.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
upload.video.google.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
*.gstatic.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
www.google.de
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh
*.googleusercontent.com
GTS CA 1C3
2024-02-05 -
2024-04-29
3 months crt.sh

This page contains 2 frames:

Primary Page: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Frame ID: F0CB8370E7CF4D37D19F73459BA07D61
Requests: 44 HTTP requests in this frame

Frame: https://googleads.g.doubleclick.net/pagead/html/r20240228/r20190131/zrt_lookup_nohtml_fy2021.html
Frame ID: 046D22B4923A3E0391E931C0A52E31CB
Requests: 1 HTTP requests in this frame

Screenshot

Page Title

PulseSight Therapeutics: Gene Therapies for Retinal Diseases

Page URL History Show full URLs

  1. http://lb.ophthalmologybreakingnews.com/eu/c/tq/102D93AB89B74DBEA488D01CF4796ED9/a56177cfe6bcc368065d2c53b59358c4/?i... HTTP 303
    https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=g... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns

Overall confidence: 100%
Detected patterns
  • <link[^>]* href=[^>]+fonts\.(?:googleapis|google)\.com

Overall confidence: 100%
Detected patterns
  • <!-- (?:End )?Google Tag Manager -->
  • googletagmanager\.com/gtm\.js
  • googletagmanager\.com/gtag/js


Page Statistics

45
Requests

100 %
HTTPS

83 %
IPv6

9
Domains

12
Subdomains

11
IPs

4
Countries

1898 kB
Transfer

4019 kB
Size

4
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://lb.ophthalmologybreakingnews.com/eu/c/tq/102D93AB89B74DBEA488D01CF4796ED9/a56177cfe6bcc368065d2c53b59358c4/?i=b19f9c9f418ddf1bbd131502e204d5ea1dd97b88b90a2b419e2559496771628dc948e72205bf496a4178a3eac66779f62d1a0dba9edd0ded6fac3609ad0ff96c7373f6bb2e014c0e12c83270294a69df5c40bf78ee6349d18eafc7aa5e701667 HTTP 303
    https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

45 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request pulsesight-introduces-novel-gene-therapies-for-retinal-diseases
ophthalmologybreakingnews.com/
Redirect Chain
  • http://lb.ophthalmologybreakingnews.com/eu/c/tq/102D93AB89B74DBEA488D01CF4796ED9/a56177cfe6bcc368065d2c53b59358c4/?i=b19f9c9f418ddf1bbd131502e204d5ea1dd97b88b90a2b419e2559496771628dc948e72205bf496a...
  • https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
40 KB
9 KB
Document
General
Full URL
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PHP/7.3.33 PleskLin
Resource Hash
59f021846f9bcde5f8a1f64427f01aa6ded66e9737ddf76594312f0f78fe0d07

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

cache-control
no-store, no-cache, must-revalidate
content-encoding
gzip
content-length
8981
content-type
text/html; charset=UTF-8
date
Fri, 01 Mar 2024 15:09:10 GMT
expires
Thu, 19 Nov 1981 08:52:00 GMT
pragma
no-cache
server
nginx
vary
Accept-Encoding
x-powered-by
PHP/7.3.33 PleskLin

Redirect headers

Cache-Control
private
Content-Type
text/html; charset=utf-8
Date
Fri, 01 Mar 2024 15:09:09 GMT
LB
20
Location
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Referer
http://lb.ophthalmologybreakingnews.com
Referrer-Policy
no-referrer
Server
Strict-Transport-Security
max-age=31536000; includeSubDomains
Transfer-Encoding
chunked
X-AspNet-Version
4.0.30319
X-Content-Type-Options
nosniff
X-Frame-Options
SAMEORIGIN
X-XSS-Protection
1; mode=block
style.min.css
ophthalmologybreakingnews.com/assets/css/
345 KB
49 KB
Stylesheet
General
Full URL
https://ophthalmologybreakingnews.com/assets/css/style.min.css?v=1001
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
73bb12ed6080e65bd61b15258d14e539e3b174e4678a30d84e314c5bbeaceb05

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Thu, 18 May 2023 13:03:33 GMT
server
nginx
etag
W/"64662225-56452"
x-powered-by
PleskLin
content-type
text/css
custom.css
ophthalmologybreakingnews.com/assets/
5 KB
1 KB
Stylesheet
General
Full URL
https://ophthalmologybreakingnews.com/assets/custom.css?v=1709305750
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
d9a7029f2b2a6aa2c7a5ec4ed1a05d046916b425e9aa6e1c2374c07989ee1a26

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Fri, 15 Sep 2023 14:45:30 GMT
server
nginx
etag
W/"65046e0a-145e"
x-powered-by
PleskLin
content-type
text/css
owl.carousel.min.css
ophthalmologybreakingnews.com/assets/owl-carousel/assets/
3 KB
880 B
Stylesheet
General
Full URL
https://ophthalmologybreakingnews.com/assets/owl-carousel/assets/owl.carousel.min.css?v=1709305750
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
5001d8f9a16bb9ba1ce1b6a0b0c0f3b95099071821a8cbff917489ae419f3a85

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Wed, 26 Jul 2023 13:45:29 GMT
server
nginx
etag
W/"64c12379-b27"
x-powered-by
PleskLin
content-type
text/css
owl.theme.default.min.css
ophthalmologybreakingnews.com/assets/owl-carousel/assets/
761 B
592 B
Stylesheet
General
Full URL
https://ophthalmologybreakingnews.com/assets/owl-carousel/assets/owl.theme.default.min.css?v=1709305750
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
900009051137e02b80917d4a668e5389e7e8e71f56ae3cadfec97aec1ce9314c

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
gzip
last-modified
Sat, 12 Nov 2022 22:52:55 GMT
server
nginx
x-accel-version
0.01
etag
"2f9-5ed4dddeb3fc0-gzip"
x-powered-by
PleskLin
vary
Accept-Encoding
content-type
text/css
accept-ranges
bytes
content-length
385
minimize-old.css
ophthalmologybreakingnews.com/assets/
10 KB
2 KB
Stylesheet
General
Full URL
https://ophthalmologybreakingnews.com/assets/minimize-old.css?v=1709305750
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
745fc6f03214131ea335dfa1e787c6ad67e66e1863164727d1c8c800f8d63335

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Thu, 31 Aug 2023 06:17:33 GMT
server
nginx
etag
W/"64f0307d-296d"
x-powered-by
PleskLin
content-type
text/css
js
www.googletagmanager.com/gtag/
269 KB
92 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-GF2N8FQV8M
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
940f890a2d8c78b6fe5d2f4c0c2cf2268081a1292c4700056ed3c6dcf0912801
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
93607
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 01 Mar 2024 15:09:11 GMT
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
146 KB
50 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5252876863963022
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
5f69f1694ac146d470f29878c3b5b0fea52c7339532c906229294927a3f922e0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://ophthalmologybreakingnews.com/
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
51159
x-xss-protection
0
server
cafe
etag
5555508175263324347
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
link
<https://googleads.g.doubleclick.net>; rel="preconnect"; crossorigin
expires
Fri, 01 Mar 2024 15:09:11 GMT
pub-5252876863963022
fundingchoicesmessages.google.com/i/
183 KB
61 KB
Script
General
Full URL
https://fundingchoicesmessages.google.com/i/pub-5252876863963022?ers=1
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
13bd0f12007a91c1aa523a360286c595cd838bf845c07caa53c67b07a2e08edf
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-e_c6Qu5KtHYJ8UoNWdyxXA' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-security-policy
script-src 'report-sample' 'nonce-e_c6Qu5KtHYJ8UoNWdyxXA' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
reporting-endpoints
default="/_/ContributorServingWebSwitchboardHttp/web-reports?context=eJzjStHikmII0JBiOO90h-k6ENcyPGNqBWIDjedMFkDM-OcFEycQv_vykonn60smCSDWAOIdPh4sfOums6oAse766ayhQBzzfDprChA7pc9gDQJin_oZrDFALMTDMf1--3o2gQfPNu5hAgAEsi2t"
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy
same-origin
server
ESF
vary
Sec-Fetch-Dest, Sec-Fetch-Mode, Sec-Fetch-Site
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
no-cache, no-store, max-age=0, must-revalidate
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
timing-allow-origin
*
expires
Mon, 01 Jan 1990 00:00:00 GMT
obn.png
ophthalmologybreakingnews.com/files/
74 KB
75 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/obn.png
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
4533761f48ca52a0ad10d8e9ca534fbe727684cfef97a16c47462a634f054b4c

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Fri, 28 Apr 2023 08:10:43 GMT
server
nginx
etag
"644b7f83-12924"
x-powered-by
PleskLin
content-type
image/png
accept-ranges
bytes
content-length
76068
OBN_Subscribe_Banner_2.jpg
ophthalmologybreakingnews.com/files/images/
118 KB
118 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/OBN_Subscribe_Banner_2.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
8c3ec838f8b5e75a33b3ec4cbedd5fdbf392384a5e4fa865e5c5827a71d34d36

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Tue, 28 Nov 2023 07:46:53 GMT
server
nginx
etag
"65659aed-1d8d6"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
121046
blog_pulsesight-therapeutics-introduces-novel-gene-therapies-for-retinal-diseases.jpg
ophthalmologybreakingnews.com/files/images/
19 KB
19 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_pulsesight-therapeutics-introduces-novel-gene-therapies-for-retinal-diseases.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
6c8b933c0bf064913f3f1398f44f135e733968f2d90c1ebbc9c42e5017ef8623

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Thu, 29 Feb 2024 06:21:28 GMT
server
nginx
etag
"65e02268-4c76"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
19574
blog_vision-councils-latest-visionwatch-report-shows-rise-in-consumer-purchasing-in-q1.jpg
ophthalmologybreakingnews.com/files/images/
61 KB
61 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_vision-councils-latest-visionwatch-report-shows-rise-in-consumer-purchasing-in-q1.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
8b9d535c449aadb43d17aa24fd88faa8bd723132d81b9b6fd3b4aebd30768d59

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Wed, 15 Dec 2021 06:47:44 GMT
server
nginx
etag
"61b98f90-f4fd"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
62717
blog_genentech-voluntarily-recalls-susvimo-ocular-implant-implantations-suspended.jpg
ophthalmologybreakingnews.com/files/images/
27 KB
27 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_genentech-voluntarily-recalls-susvimo-ocular-implant-implantations-suspended.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
13c49895f45d7878c8e61a4aa63e4e7ad7cfd0cdd107041a608f27cf7722d50e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Thu, 20 Oct 2022 06:45:13 GMT
server
nginx
etag
"6350ee79-6c5a"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
27738
blog_edenlux-launches-campaign-for-otus-personal-eye-trainer-to-prevent-eye-health-issues_1.jpg
ophthalmologybreakingnews.com/files/images/
33 KB
34 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_edenlux-launches-campaign-for-otus-personal-eye-trainer-to-prevent-eye-health-issues_1.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
598d0db821cf5d84cf92fb84929386cab771a1b7740b7e8482b7637b9362e30a

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Fri, 11 Aug 2023 06:06:19 GMT
server
nginx
etag
"64d5cfdb-85c2"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
34242
780x450.png
ophthalmologybreakingnews.com/files/images/
3 KB
3 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/780x450.png
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
009e8f8523d30189c005dc269a3ab7285723c1371c402e9068e0b305f99d24f2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Wed, 15 Dec 2021 06:47:44 GMT
server
nginx
etag
"61b98f90-aea"
x-powered-by
PleskLin
content-type
image/png
accept-ranges
bytes
content-length
2794
blog_micro-labs-launches-worlds-first-triple-drug-fdc-for-glaucoma.jpg
ophthalmologybreakingnews.com/files/images/
31 KB
31 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_micro-labs-launches-worlds-first-triple-drug-fdc-for-glaucoma.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
5a0411d79b2dd84a44bec0e5acdad28e69247b9fe2551bf224e96c04472901a7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Mon, 14 Aug 2023 07:22:32 GMT
server
nginx
etag
"64d9d638-7b44"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
31556
blog_high-tech-contact-lenses-may-replace-smart-phones.jpg
ophthalmologybreakingnews.com/files/images/
35 KB
35 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_high-tech-contact-lenses-may-replace-smart-phones.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
2706c558149f622f8c9e62b8f6b93ecc9857edfe10ba5fc15d448cba88df8b76

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Wed, 15 Dec 2021 06:47:44 GMT
server
nginx
etag
"61b98f90-8cb5"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
36021
blog_fda-declines-to-approve-outlook-therapeutics-lytenava-for-wet-amd.jpg
ophthalmologybreakingnews.com/files/images/
19 KB
19 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_fda-declines-to-approve-outlook-therapeutics-lytenava-for-wet-amd.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
d458aa8f5a58ab10239dc8f0bc9fce587481002dec764ff1521a260bdc66e669

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Thu, 31 Aug 2023 06:18:45 GMT
server
nginx
etag
"64f030c5-4bfd"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
19453
blog_researchers-groundbreaking-ai-system-set-to-transform-eye-care.jpg
ophthalmologybreakingnews.com/files/images/
47 KB
47 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_researchers-groundbreaking-ai-system-set-to-transform-eye-care.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
3865647d76a4d87173850235e439420342241264d60452feab0cd7d57b30a8d7

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Thu, 14 Sep 2023 12:25:11 GMT
server
nginx
etag
"6502fba7-bb68"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
47976
blog_new-study-reveals-negative-effect-of-atropine-drops-after-glaucoma-surgery.jpg
ophthalmologybreakingnews.com/files/images/
49 KB
49 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_new-study-reveals-negative-effect-of-atropine-drops-after-glaucoma-surgery.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
fa53a6d8bfbdc7c6b63fbee96f0bf0571b9392fca0ef33cf3a9da6435af1cb45

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Mon, 30 Jan 2023 11:25:17 GMT
server
nginx
etag
"63d7a91d-c419"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
50201
logo(1).png
ophthalmologybreakingnews.com/files/images/
208 KB
209 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/logo(1).png
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
6390abaa3560c50cd4ab8e9b6c99fd2f39b4095d120b044e7ff8b8480e4a8621

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Fri, 28 Apr 2023 08:42:24 GMT
server
nginx
etag
"644b86f0-3414f"
x-powered-by
PleskLin
content-type
image/png
accept-ranges
bytes
content-length
213327
exon_logo_new.png
ophthalmologybreakingnews.com/files/images/
8 KB
8 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/exon_logo_new.png
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
acfb41c4de1d015a6fcff690f07666035db197213e54932b5a6308d92f08d93e

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Wed, 15 Dec 2021 06:47:44 GMT
server
nginx
etag
"61b98f90-2157"
x-powered-by
PleskLin
content-type
image/png
accept-ranges
bytes
content-length
8535
hataman.min.js
ophthalmologybreakingnews.com/assets/js/
371 KB
103 KB
Script
General
Full URL
https://ophthalmologybreakingnews.com/assets/js/hataman.min.js
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
f0e4c3214a34269e8baafe58a8920fd6f2230eec810373aeaa2f4bca44981378

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Wed, 02 Nov 2022 15:15:54 GMT
server
nginx
etag
W/"636289aa-5ccd9"
x-powered-by
PleskLin
content-type
application/javascript
custom.js
ophthalmologybreakingnews.com/assets/
2 KB
777 B
Script
General
Full URL
https://ophthalmologybreakingnews.com/assets/custom.js
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
44a8834c15c0eaa26564edfb0c1d3b848c884450b598ac294bc9eb8199e78da2

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
last-modified
Thu, 05 Oct 2023 10:36:09 GMT
server
nginx
etag
W/"651e9199-927"
x-powered-by
PleskLin
content-type
application/javascript
css2
fonts.googleapis.com/
17 KB
2 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;600;700&display=swap
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/assets/css/style.min.css?v=1001
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
851699a18b631a7bd68efc99598701293a6065b463fced7b68d8d6d9227bd8e7
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Fri, 01 Mar 2024 13:36:05 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Fri, 01 Mar 2024 15:09:11 GMT
gtm.js
www.googletagmanager.com/
177 KB
65 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-M4H22MT
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
66efddf6345a2d6735da5c802312ce285aa74622a33c538b1158297e698109a8
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
65876
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 01 Mar 2024 15:09:11 GMT
memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
fonts.gstatic.com/s/opensans/v40/
47 KB
48 KB
Font
General
Full URL
https://fonts.gstatic.com/s/opensans/v40/memvYaGs126MiZpBA-UvWbX2vVnXBbObj2OVTS-muw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Open+Sans:wght@400;600;700&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3c4d6a1421c7ddb7e404521fe8c4cd5be5af446d7689cd880be26612eaad3cfa
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Wed, 28 Feb 2024 04:08:42 GMT
x-content-type-options
nosniff
age
212429
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
48236
x-xss-protection
0
last-modified
Thu, 14 Dec 2023 02:08:40 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 27 Feb 2025 04:08:42 GMT
fontawesome-webfont.woff2
ophthalmologybreakingnews.com/assets/fonts/
75 KB
76 KB
Font
General
Full URL
https://ophthalmologybreakingnews.com/assets/fonts/fontawesome-webfont.woff2?v=4.7.0
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/assets/css/style.min.css?v=1001
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
2adefcbc041e7d18fcf2d417879dc5a09997aa64d675b7a3c4b6ce33da13f3fe

Request headers

Referer
https://ophthalmologybreakingnews.com/assets/css/style.min.css?v=1001
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Wed, 15 Dec 2021 06:47:44 GMT
server
nginx
etag
"61b98f90-12d68"
x-powered-by
PleskLin
content-type
font/woff2
accept-ranges
bytes
content-length
77160
blog_ontarios-expansion-of-private-cataract-clinics-faces-billing-complaints.jpg
ophthalmologybreakingnews.com/files/images/
44 KB
45 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_ontarios-expansion-of-private-cataract-clinics-faces-billing-complaints.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
72b3e06fc2c8e836268f1d93fd34edf59c138c33bbee5f354012bf2135e258f6

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Mon, 26 Feb 2024 06:32:36 GMT
server
nginx
etag
"65dc3084-b17a"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
45434
blog_revolutionary-printable-retinas-could-restore-color-vision.jpg
ophthalmologybreakingnews.com/files/images/
42 KB
42 KB
Image
General
Full URL
https://ophthalmologybreakingnews.com/files/images/blog_revolutionary-printable-retinas-could-restore-color-vision.jpg
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
188.132.199.152 , Turkey, ASN48678 (TR-PENTECH-AS, TR),
Reverse DNS
Software
nginx / PleskLin
Resource Hash
b778d8803e56ec8637cd0811c9bc11cfa116100234233d43f392622787495d7f

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
last-modified
Tue, 20 Feb 2024 05:58:41 GMT
server
nginx
etag
"65d43f91-a6ea"
x-powered-by
PleskLin
content-type
image/jpeg
accept-ranges
bytes
content-length
42730
show_ads_impl_with_ama_fy2021.js
pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402260101/
407 KB
138 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-5252876863963022&plah=ophthalmologybreakingnews.com&aplac=true
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5252876863963022
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
610125c46303e1cf228d8451c69cd3aadbe3d4c03702b045d1eec12667804fca
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
141124
x-xss-protection
0
server
cafe
etag
5122359674032889854
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600, stale-while-revalidate=3600
timing-allow-origin
*
expires
Fri, 01 Mar 2024 15:09:11 GMT
zrt_lookup_nohtml_fy2021.html
googleads.g.doubleclick.net/pagead/html/r20240228/r20190131/ Frame 046D
9 KB
4 KB
Document
General
Full URL
https://googleads.g.doubleclick.net/pagead/html/r20240228/r20190131/zrt_lookup_nohtml_fy2021.html
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5252876863963022
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
df7a397b8ce58f6251a395e02608b4f620e934a958bdfe6702c6f2033593eed0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://ophthalmologybreakingnews.com/
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36
accept-language
de-DE,de;q=0.9

Response headers

age
73273
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
cache-control
public, max-age=1209600
content-encoding
br
content-length
4155
content-type
text/html; charset=UTF-8
cross-origin-resource-policy
cross-origin
date
Thu, 29 Feb 2024 18:47:58 GMT
etag
5035419970550746386
expires
Thu, 14 Mar 2024 18:47:58 GMT
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
server
cafe
timing-allow-origin
*
vary
Accept-Encoding
x-content-type-options
nosniff
x-xss-protection
0
js
www.googletagmanager.com/gtag/
266 KB
91 KB
Script
General
Full URL
https://www.googletagmanager.com/gtag/js?id=G-GF2N8FQV8M&l=dataLayer&cx=c
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-M4H22MT
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
78cdb0e10f03fffc17fb22cae98bcf648bdc11045658ba57dae1290f7df831be
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-encoding
br
strict-transport-security
max-age=31536000; includeSubDomains
server
Google Tag Manager
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
access-control-allow-headers
Cache-Control
content-length
92628
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
expires
Fri, 01 Mar 2024 15:09:11 GMT
AGSKWxVZ23h9cvuy8Ml_1L1WCsuVwXJSqu1OR769d-yPOsIsjWSjknjPjA9dp1K0tgXReG_3tuL3R_4ellTtrQW5FC9xZbtxmrFZ-qhpkwjBcRO3ptmYfWkHZr5I41t0aRDKC7PoEAs2xA==
fundingchoicesmessages.google.com/f/
380 KB
58 KB
Script
General
Full URL
https://fundingchoicesmessages.google.com/f/AGSKWxVZ23h9cvuy8Ml_1L1WCsuVwXJSqu1OR769d-yPOsIsjWSjknjPjA9dp1K0tgXReG_3tuL3R_4ellTtrQW5FC9xZbtxmrFZ-qhpkwjBcRO3ptmYfWkHZr5I41t0aRDKC7PoEAs2xA==?fccs=W251bGwsbnVsbCxudWxsLG51bGwsbnVsbCxudWxsLFsxNzA5MzA1NzUxLDgxMjAwMDAwMF0sbnVsbCxudWxsLG51bGwsW251bGwsWzddXSwiaHR0cHM6Ly9vcGh0aGFsbW9sb2d5YnJlYWtpbmduZXdzLmNvbS9wdWxzZXNpZ2h0LWludHJvZHVjZXMtbm92ZWwtZ2VuZS10aGVyYXBpZXMtZm9yLXJldGluYWwtZGlzZWFzZXMiLG51bGwsW1s4LCJ2enJOdkhRLWN5byJdLFs5LCJkZSJdLFsyMCwiW251bGwsbnVsbCxbOTUzMjU5OTFdLG51bGwsMTRdIl0sWzE5LCIxIl1dXQ
Requested by
Host:
URL: /_/mss/boq-content-ads-contributor/_/js/k=boq-content-ads-contributor.ContributorServingResponseClientJs.de.vzrNvHQ-cyo.es5.O/am=wA/d=1/rs=AJlcJMwQF2fskyAOycMmVP1q4f6hVo0GBQ/m=kernel_loader,loader_js_executable
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
9ad4be7a18b9a302f6a73e597a16fcb5185a60432ece2724f81c2c5015c0b816
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-Fs7ZBTkr-MAWSBgi2yG93A' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorGlobalRouterHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorGlobalRouterHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorGlobalRouterHttp/cspreport
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:11 GMT
content-security-policy
script-src 'report-sample' 'nonce-Fs7ZBTkr-MAWSBgi2yG93A' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorGlobalRouterHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorGlobalRouterHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorGlobalRouterHttp/cspreport
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
reporting-endpoints
default="/_/ContributorGlobalRouterHttp/web-reports?context=eJzjStHikmJw1pBiOO90h-k6ENcyPGNqBWIDjedMFkDM-OcFEycQv_vykonn60smCSDWAOIdPh4sfOums6oAse766ayhQBzzfDprChA7pc9gDQJin_oZrDFALMTDMf1--3o2gQ1fnhxhBgD-_y26"
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy
same-origin
server
ESF
vary
Sec-Fetch-Dest, Sec-Fetch-Mode, Sec-Fetch-Site
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
no-cache, no-store, max-age=0, must-revalidate
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
timing-allow-origin
*
expires
Mon, 01 Jan 1990 00:00:00 GMT
collect
region1.analytics.google.com/g/
0
264 B
Ping
General
Full URL
https://region1.analytics.google.com/g/collect?v=2&tid=G-GF2N8FQV8M&gtm=45je42s0v876577595za200&_p=1709305751451&_gaz=1&gcd=13l3l3l3l1&npa=0&dma_cps=sypham&dma=1&tcfd=10001&cid=355367049.1709305752&ul=en-us&sr=1600x1200&uaa=&uab=&uafvl=&uamb=0&uam=&uap=&uapv=&uaw=0&pscdl=noapi&_s=1&sid=1709305751&sct=1&seg=0&dl=https%3A%2F%2Fophthalmologybreakingnews.com%2Fpulsesight-introduces-novel-gene-therapies-for-retinal-diseases%3Futm_source%3Dgoogle%26utm_medium%3Demail%26utm_campaign%3Dobnsite&dt=PulseSight%20Therapeutics%3A%20Gene%20Therapies%20for%20Retinal%20Diseases&en=page_view&_fv=1&_nsi=1&_ss=1&_ee=1&tfd=5259
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-GF2N8FQV8M
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4860:4802:32::36 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 01 Mar 2024 15:09:11 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ophthalmologybreakingnews.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/g/
0
264 B
Ping
General
Full URL
https://stats.g.doubleclick.net/g/collect?v=2&tid=G-GF2N8FQV8M&cid=355367049.1709305752&gtm=45je42s0v876577595za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=G-GF2N8FQV8M
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c00::9a Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 01 Mar 2024 15:09:11 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://ophthalmologybreakingnews.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
408 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?v=1&t=sr&slf_rd=1&_r=4&tid=G-GF2N8FQV8M&cid=355367049.1709305752&gtm=45je42s0v876577595za200&aip=1&dma=1&dma_cps=sypham&gcd=13l3l3l3l1&npa=0&z=957625889
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:827::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

pragma
no-cache
date
Fri, 01 Mar 2024 15:09:11 GMT
x-content-type-options
nosniff
server
cafe
content-type
image/gif
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
css
fonts.googleapis.com/
107 KB
6 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css?family=Archivo:400,500|Arimo:400,500|Bitter:400,500|EB+Garamond:400,500|Lato|Libre+Baskervill|Libre+Franklin:400,500|Lora:400,500|Google+Sans:regular,medium:400,500|Material+Icons|Google+Symbols|Merriweather|Montserrat:400,500|Mukta:400,500|Muli:400,500|Nunito:400,500|Open+Sans:400,500,600|Open+Sans+Condensed:400,600|Oswald:500|Playfair+Display:400,500|Poppins:400,500|Raleway:400,500|Roboto:400,500|Roboto+Condensed:400,500|Roboto+Slab:400,500|Slabo+27px|Source+Sans+Pro|Ubuntu:400,500|Volkhov&display=swap
Requested by
Host:
URL: /_/mss/boq-content-ads-contributor/_/js/k=boq-content-ads-contributor.ContributorServingResponseClientJs.de.vzrNvHQ-cyo.es5.O/d=1/exm=kernel_loader,loader_js_executable/ed=1/rs=AJlcJMwyFLpNKY2V7TORlzEb8_ENYoGtZQ/m=web_iab_tcf_v2_wall_executable
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80f::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
d887816ae8b346d63ebc061959c1b52232e29a7f0f7b72a28a8a89db6f163348
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
date
Fri, 01 Mar 2024 15:09:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
last-modified
Fri, 01 Mar 2024 15:09:12 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Fri, 01 Mar 2024 15:09:12 GMT
yMseHvC3yOmKOs6KR6FqmOa3Qjlg46Tr6o6LATXbixQYv6Z_16p5UToNk8ouJ3FTzZxLFEFTNt_AV_JkL5jdz2YzRmw9B4jOqVFPsWtvXDQ3uZNQXOMjTg=h60
lh3.googleusercontent.com/
1 KB
2 KB
Image
General
Full URL
https://lh3.googleusercontent.com/yMseHvC3yOmKOs6KR6FqmOa3Qjlg46Tr6o6LATXbixQYv6Z_16p5UToNk8ouJ3FTzZxLFEFTNt_AV_JkL5jdz2YzRmw9B4jOqVFPsWtvXDQ3uZNQXOMjTg=h60
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
fife /
Resource Hash
4e292f912413d695a1243a36a955d34300ed8dc4f7436443ff2d0e00905125b2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:00:25 GMT
x-content-type-options
nosniff
age
527
cross-origin-resource-policy
cross-origin
content-disposition
inline;filename="unnamed.jpg"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
1314
x-xss-protection
0
server
fife
etag
"v1"
vary
Origin
content-type
image/jpeg
access-control-allow-origin
*
access-control-expose-headers
Content-Length
cache-control
public, max-age=86400, no-transform
timing-allow-origin
*
expires
Sat, 02 Mar 2024 15:00:25 GMT
flUhRq6tzZclQEJ-Vdg-IuiaDsNc.woff2
fonts.gstatic.com/s/materialicons/v140/
125 KB
126 KB
Font
General
Full URL
https://fonts.gstatic.com/s/materialicons/v140/flUhRq6tzZclQEJ-Vdg-IuiaDsNc.woff2
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8265f64786397d6b832d1ca0aafdf149ad84e72759fffa9f7272e91a0fb015d1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://ophthalmologybreakingnews.com/
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 08:54:17 GMT
x-content-type-options
nosniff
age
281695
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
128352
x-xss-protection
0
last-modified
Tue, 07 Mar 2023 19:51:56 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 26 Feb 2025 08:54:17 GMT
KFOmCnqEu92Fr1Mu4mxK.woff2
fonts.gstatic.com/s/roboto/v18/
15 KB
15 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v18/KFOmCnqEu92Fr1Mu4mxK.woff2
Requested by
Host: ophthalmologybreakingnews.com
URL: https://ophthalmologybreakingnews.com/pulsesight-introduces-novel-gene-therapies-for-retinal-diseases?utm_source=google&utm_medium=email&utm_campaign=obnsite
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
3e253b66056519aa065b00a453bac37ac5ed8f3e6fe7b542e93a9dcdcc11d0bc
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://ophthalmologybreakingnews.com/
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 09:03:23 GMT
x-content-type-options
nosniff
age
281149
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15344
x-xss-protection
0
last-modified
Mon, 16 Oct 2017 17:32:55 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 26 Feb 2025 09:03:23 GMT
AGSKWxXwg32XBY1p-rWbmgdp_bkJ1hEj-6lDCX60LntkWqJWBA7Y2nwYqMgLd8NFrgOy0PiQotK4o_XC7PCUGgLxTHYzQKPRikSbvDTEoe7-Kahf0WhqzyySt3QqFZrpyXKr4WBk41snjg==
fundingchoicesmessages.google.com/el/
0
29 B
XHR
General
Full URL
https://fundingchoicesmessages.google.com/el/AGSKWxXwg32XBY1p-rWbmgdp_bkJ1hEj-6lDCX60LntkWqJWBA7Y2nwYqMgLd8NFrgOy0PiQotK4o_XC7PCUGgLxTHYzQKPRikSbvDTEoe7-Kahf0WhqzyySt3QqFZrpyXKr4WBk41snjg==
Requested by
Host:
URL: /_/mss/boq-content-ads-contributor/_/js/k=boq-content-ads-contributor.ContributorServingResponseClientJs.de.vzrNvHQ-cyo.es5.O/am=wA/d=1/rs=AJlcJMwQF2fskyAOycMmVP1q4f6hVo0GBQ/m=kernel_loader,loader_js_executable
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Content-Security-Policy require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce-0tRP8k4HKabw9-ztV28idQ' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Referer
https://ophthalmologybreakingnews.com/
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36
Content-Type
text/plain

Response headers

date
Fri, 01 Mar 2024 15:09:12 GMT
content-security-policy
require-trusted-types-for 'script';report-uri /_/ContributorLoggingHttp/cspreport, script-src 'report-sample' 'nonce-0tRP8k4HKabw9-ztV28idQ' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorLoggingHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorLoggingHttp/cspreport/allowlist
x-content-type-options
nosniff
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
0
x-xss-protection
0
reporting-endpoints
default="/_/ContributorLoggingHttp/web-reports?context=eJzjUtHikmLw1ZBiqGV4xtQKxIx_XjBxAvEOHw8Wp_QZrCFALMTNMeN--3o2gYbzZ3wBecUQ8g"
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy
same-origin
server
ESF
access-control-max-age
86400
vary
Sec-Fetch-Dest, Sec-Fetch-Mode, Sec-Fetch-Site
content-type
text/html; charset=utf-8
access-control-allow-origin
https://ophthalmologybreakingnews.com
access-control-allow-methods
POST, GET, OPTIONS
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
x-frame-options
SAMEORIGIN
expires
Mon, 01 Jan 1990 00:00:00 GMT
ca-pub-5252876863963022
fundingchoicesmessages.google.com/i/
183 KB
60 KB
Script
General
Full URL
https://fundingchoicesmessages.google.com/i/ca-pub-5252876863963022?ers=2
Requested by
Host: pagead2.googlesyndication.com
URL: https://pagead2.googlesyndication.com/pagead/managed/js/adsense/m202402260101/show_ads_impl_with_ama_fy2021.js?client=ca-pub-5252876863963022&plah=ophthalmologybreakingnews.com&aplac=true
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:80f::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
b76248a63ae10c55ecffb10100f60c13fbb3f23be51f7186398a55dc8cfd1992
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-4XSptmSxbVrTmMgEXeLAEg' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

accept-language
de-DE,de;q=0.9
Referer
https://ophthalmologybreakingnews.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Fri, 01 Mar 2024 15:09:12 GMT
content-security-policy
script-src 'report-sample' 'nonce-4XSptmSxbVrTmMgEXeLAEg' 'unsafe-inline';object-src 'none';base-uri 'self';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport;worker-src 'self', script-src 'unsafe-inline' 'self' https://apis.google.com https://ssl.gstatic.com https://www.google.com https://www.googletagmanager.com https://www.gstatic.com https://www.google-analytics.com;report-uri /_/ContributorServingWebSwitchboardHttp/cspreport/allowlist, require-trusted-types-for 'script';report-uri /_/ContributorServingWebSwitchboardHttp/cspreport
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
x-xss-protection
0
reporting-endpoints
default="/_/ContributorServingWebSwitchboardHttp/web-reports?context=eJzjStHikmII0JBiOO90h-k6ENcyPGNqBWIDjedMFkDM-OcFEycQv_vykonn60smCSDWAOIdPh4sfOums6oAse766ayhQBzzfDprChA7pc9gDQJin_oZrDFALMTNMeN--3o2gQ2z55oDANSmLJc"
pragma
no-cache
accept-ch
Sec-CH-UA-Arch, Sec-CH-UA-Bitness, Sec-CH-UA-Full-Version, Sec-CH-UA-Full-Version-List, Sec-CH-UA-Model, Sec-CH-UA-WoW64, Sec-CH-UA-Form-Factor, Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version
cross-origin-opener-policy
same-origin
server
ESF
vary
Sec-Fetch-Dest, Sec-Fetch-Mode, Sec-Fetch-Site
x-frame-options
SAMEORIGIN
content-type
application/javascript; charset=utf-8
cache-control
no-cache, no-store, max-age=0, must-revalidate
permissions-policy
ch-ua-arch=*, ch-ua-bitness=*, ch-ua-full-version=*, ch-ua-full-version-list=*, ch-ua-model=*, ch-ua-wow64=*, ch-ua-form-factor=*, ch-ua-platform=*, ch-ua-platform-version=*
timing-allow-origin
*
expires
Mon, 01 Jan 1990 00:00:00 GMT
KFOlCnqEu92Fr1MmEU9fBBc4.woff2
fonts.gstatic.com/s/roboto/v30/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/roboto/v30/KFOlCnqEu92Fr1MmEU9fBBc4.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css?family=Archivo:400,500|Arimo:400,500|Bitter:400,500|EB+Garamond:400,500|Lato|Libre+Baskervill|Libre+Franklin:400,500|Lora:400,500|Google+Sans:regular,medium:400,500|Material+Icons|Google+Symbols|Merriweather|Montserrat:400,500|Mukta:400,500|Muli:400,500|Nunito:400,500|Open+Sans:400,500,600|Open+Sans+Condensed:400,600|Oswald:500|Playfair+Display:400,500|Poppins:400,500|Raleway:400,500|Roboto:400,500|Roboto+Condensed:400,500|Roboto+Slab:400,500|Slabo+27px|Source+Sans+Pro|Ubuntu:400,500|Volkhov&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:80e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
b019538234514166ec7665359d097403358f8a4c991901983922fb4d56989f1e
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://ophthalmologybreakingnews.com
accept-language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/122.0.6261.94 Safari/537.36

Response headers

date
Tue, 27 Feb 2024 09:10:25 GMT
x-content-type-options
nosniff
age
280727
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
15920
x-xss-protection
0
last-modified
Wed, 11 May 2022 19:24:45 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="apps-themes"
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 26 Feb 2025 09:10:25 GMT

Verdicts & Comments Add Verdict or Comment

66 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| dataLayer function| gtag object| adsbygoogle object| google_js_reporting_queue number| google_srt object| google_persistent_state_async object| google_logging_queue number| tmod object| google_ad_modifications object| ggeac boolean| google_measure_js_timing object| google_tag_data object| google_reactive_ads_global_state object| google_sa_queue function| google_process_slots object| google_ama_state function| google_spfd number| google_unique_id object| google_sv_map number| google_rum_task_id_counter string| google_user_agent_client_hint object| google_tag_manager function| checkMenuSize function| goToByScroll function| $ function| jQuery function| Tether function| Popper boolean| jquery_mmenu_all_js function| setImmediate function| clearImmediate function| swal function| sweetAlert object| cookieconsent object| default_ContributorServingResponseClientJs object| _F_toggles object| __googlefc string| __fcInvoked string| __fcexpdef string| ZTU5YTZjZGNiOGFjYmQ4ZGxvYWRlcl9qcw== string| ZTU5YTZjZGNiOGFjYmQ4ZGNhY2hlZF9qcw== object| googlefc object| __fcInternalApiManager boolean| __fcInternalApiPostMessageReady object| __tcfapiEventListeners function| __tcfapi object| __tcfapiManager boolean| __tcfapiPostMessageReady function| __uspapi object| __uspapiManager boolean| __uspapiPostMessageReady object| __gppEventListeners function| __gpp object| __gppManager boolean| __gppPostMessageReady function| onYouTubeIframeAPIReady object| gaGlobal function| google_sa_impl boolean| adsbygoogle_ama_fc_has_run

4 Cookies

Domain/Path Name / Value
lb.ophthalmologybreakingnews.com/ Name: ASP.NET_SessionId
Value: dekfigfxcv4navhy3jarm4tz
ophthalmologybreakingnews.com/ Name: PHPSESSID
Value: n7rr9con2d4muj56urgn7mte8r
.ophthalmologybreakingnews.com/ Name: _ga_GF2N8FQV8M
Value: GS1.1.1709305751.1.0.1709305751.60.0.0
.ophthalmologybreakingnews.com/ Name: _ga
Value: GA1.1.355367049.1709305752

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

fonts.googleapis.com
fonts.gstatic.com
fundingchoicesmessages.google.com
googleads.g.doubleclick.net
lb.ophthalmologybreakingnews.com
lh3.googleusercontent.com
ophthalmologybreakingnews.com
pagead2.googlesyndication.com
region1.analytics.google.com
stats.g.doubleclick.net
www.google.de
www.googletagmanager.com
188.132.199.152
2001:4860:4802:32::36
2a00:1450:4001:808::2002
2a00:1450:4001:80e::2003
2a00:1450:4001:80f::2002
2a00:1450:4001:80f::200a
2a00:1450:4001:80f::200e
2a00:1450:4001:811::2001
2a00:1450:4001:827::2003
2a00:1450:4001:831::2008
2a00:1450:400c:c00::9a
91.235.64.15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